ALPINE IMMUNE SCIENCES, INC. Stock Agreements
15 Contracts & Agreements
- Description of Capital Stock (Filed With SEC on March 20, 2024)
- Form of Stand-Alone Inducement Stock Option Grant between the Registrant and (Filed With SEC on November 14, 2023)
- Form of Stand-Alone Inducement Stock Option Grant between the Registrant and (Filed With SEC on November 14, 2023)
- Description of Capital Stock (Filed With SEC on March 23, 2023)
- Form of Stand-Alone Inducement Stock Option Grant between the Company and Andrew Sandler (Filed With SEC on November 14, 2022)
- Stock Purchase Agreement, dated December 15, 2021 by and between Alpine Immune Sciences, Inc. and Horizon Therapeutics Ireland DAC (Filed With SEC on March 17, 2022)
- Form of Stand-Alone Inducement Stock Option Grant between the Company and Zelanna Goldberg (Filed With SEC on August 10, 2021)
- Description of Capital Stock (Filed With SEC on March 18, 2021)
- Description of Capital Stock (Filed With SEC on March 30, 2020)
- Form of Stand-Alone Inducement Stock Option Grant (Filed With SEC on August 6, 2018)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on March 28, 2018)
- NOTICE OF RESTRICTED STOCK UNIT INDUCEMENT GRANT NIVALIS THERAPEUTICS, INC. (Filed With SEC on May 3, 2016)
- NOTICE OF INDUCEMENT STOCK OPTION GRANT NIVALIS THERAPEUTICS, INC. (Filed With SEC on May 3, 2016)
- NIVALIS THERAPEUTICS, INC. EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 13, 2015)
- NIVALIS THERAPEUTICS, INC. a Delaware Corporation Incorporated on July 31, 2012 Common Stock Par Value: $0.001 (Filed With SEC on May 13, 2015)
